<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7279248\results\search\testTrace\results.xml">
  <result pre="current therapeutic guidelines recommend supportive care including oxygen administration and" exact="treatment" post="with antibiotics. Recently, patients have been also treated with"/>
  <result pre="inhibitors endoplasmic stress UPR response 1. Introduction Since December 2019," exact="infection" post="with the severe acute respiratory coronavirus 2 (SARS-CoV-2) has"/>
  <result pre="on a global scale [3,4]. Unfortunately, the symptoms of SARS-CoV-2" exact="infection" post="can vary in an unpredictable manner; there are asymptomatic"/>
  <result pre="therapy, current management consists of supportive care, including ventilation and" exact="treatment" post="with antibiotics [8,9]. Moreover, patients are often treated with"/>
  <result pre="result in a better binding affinity for ACE2 [34]. Systematic" exact="detection" post="of Î²-CoV receptors has shown that human cells expressing"/>
  <result pre="document summarizing its guidelines and scientific evidence derived from the" exact="treatment" post="of previous HCoV epidemics [30]. Furthermore, the scientific world"/>
  <result pre="the fight against SARS-CoV and MERS-CoV, antiviral drugs and systemic" exact="treatment" post="with corticosteroids commonly used previously in clinical practice, including"/>
  <result pre="every 12 h), drugs used for many years in the" exact="treatment" post="of malaria, and today also in the treatment of"/>
  <result pre="in the treatment of malaria, and today also in the" exact="treatment" post="of rheumatoid arthritis. Several possible mechanisms have been studied."/>
  <result pre="of different viruses [44], with a powerful effect on the" exact="infection" post="and spread of SARS-CoV [45]. Furthermore, chloroquine has immuno-modulatory"/>
  <result pre="worked in both the entry and postentry stages of COVID-19" exact="infection" post="in Vero E6 cells [41]. In Italy, a large"/>
  <result pre="directed against the IL-6 receptor and commonly used in the" exact="treatment" post="of rheumatoid arthritis. Passive immunization has been successfully used"/>
  <result pre="rheumatoid arthritis. Passive immunization has been successfully used for the" exact="treatment" post="of infectious diseases, and 80 SARS patients were treated"/>
  <result pre="convalescent plasma during the last major outbreak, while the same" exact="treatment" post="did not occur for MERS. Since many patients have"/>
  <result pre="of a functional UPS. Several studies have shown that virus" exact="infection" post="leads to the accumulation of proteinâ€&quot;ubiquitin conjugates, suggesting an"/>
  <result pre="was approved in 2008 as a first-line drug in the" exact="treatment" post="of multiple myeloma. Other inhibitors are MG132, Lactacistin, Carfilzomib,"/>
  <result pre="Studies showed that Carfilzomib is a good candidate for the" exact="treatment" post="of COVID-19 [53]. As mentioned, one of the effects"/>
  <result pre="COVID-19 [53]. As mentioned, one of the effects of coronavirus" exact="infection" post="is the pro-inflammatory cytokine storm that occurs mainly in"/>
  <result pre="the authors attempted to determine whether the inhibition of virus" exact="infection" post="caused by MG132 was specific to this proteasome inhibitor"/>
  <result pre="RuxolitinibFront. Oncol.20199118610.3389/fonc.2019.0118631788449 15.ZhangW.ZhaoY.ZhangF.WangQ.LiT.LiuZ.WangJ.QinY.ZhangX.YanX.et al.The use of anti-inflammatory drugs in the" exact="treatment" post="of people with severe coronavirus disease 2019 (COVID-19): The"/>
  <result pre="Infect. Dis.2003372272710.1016/S1473-3099(03)00806-514592603 45.VincentM.J.BergeronE.BenjannetS.EricksonB.R.RollinP.E.KsiazekT.G.SeidahN.G.NicholS.T.Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol. J.200510.1186/1743-422X-2-6916115318 46.Casorla-PÃ©rezL.A.LÃ³pezT.LÃ³pezS.AriasC.F.The Ubiquitin-Proteasome System Is Necessary for"/>
 </snippets>
</snippetsTree>
